New Breakthroughs in Gene Therapy
Monday, June 25, 2018 - 6:00pm to 7:30pm
A revolutionary new therapy is rapidly emerging for the treatment of some forms of cancer. CAR-T cell therapies genetically engineer a patient’s own immune cells to treat cancer with results that have captured the attention of researchers and the public alike. In 2017, CAR-T cell therapy was the first gene therapy treatment approved in the United States by the Food and Drug Administration (FDA).
Dr. Saar Gill is part of a team that pioneered this experimental treatment at the University of Pennsylvania. Joined by The Franklin Institute’s Chief Bioscientist Dr. Jayatri Das, Gill will delve into an exploration of CAR-T cell therapy—the science behind it, its risks and benefits, plus its potential for treating other forms of cancer.
Dr. Jayatri Das, Chief Bioscientist, The Franklin Institute
Saar Gill, MD, Ph.D. | Assistant Professor of Medicine, University of Pennsylvania Perelman School of Medicine
Free; Advance Registration Required SOLD OUT